• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Delayed psychotropic toxicity after switching from nevirapine to bictegravir: the role of enzyme de-induction in people with HIV and polypharmacy.

作者信息

Pozza Giacomo, Giacomelli Andrea, Ridolfo Annalisa, Cossu Maria Vittoria, Gori Andrea, Cattaneo Dario, Gervasoni Cristina

机构信息

Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.

Department of Biomedical and Clinical Sciences, Università Degli Studi Di Milano, Milan, Italy.

出版信息

Eur J Clin Pharmacol. 2025 Sep;81(9):1375-1376. doi: 10.1007/s00228-025-03873-z. Epub 2025 Jul 1.

DOI:10.1007/s00228-025-03873-z
PMID:40593164
Abstract
摘要

相似文献

1
Delayed psychotropic toxicity after switching from nevirapine to bictegravir: the role of enzyme de-induction in people with HIV and polypharmacy.从奈韦拉平转换为比克替拉韦后的迟发性精神药物毒性：酶去诱导在HIV感染者和多药治疗中的作用
Eur J Clin Pharmacol. 2025 Sep;81(9):1375-1376. doi: 10.1007/s00228-025-03873-z. Epub 2025 Jul 1.
2
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial.多替拉韦与拉米夫定维持治疗对比比克替拉韦、恩曲他滨和替诺福韦艾拉酚胺用于HIV感染者（PASO-DOBLE）：一项随机、多中心、开放标签、非劣效性试验的48周结果
Lancet HIV. 2025 Jul;12(7):e473-e484. doi: 10.1016/S2352-3018(25)00105-5. Epub 2025 Jun 7.
3
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trial.比克替拉韦、恩曲他滨和替诺福韦艾拉酚胺与基于利托那韦增强型蛋白酶抑制剂的抗逆转录病毒疗法用于海地接受二线治疗且病毒得到抑制的HIV感染者：一项开放标签、随机、非劣效性试验。
Lancet HIV. 2025 Sep;12(9):e616-e626. doi: 10.1016/S2352-3018(25)00130-4.
4
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.在病毒学抑制的 HIV 儿童患者（年龄 2 岁及以上）中，双替拉韦、恩曲他滨和丙酚替诺福韦二吡呋酯复方制剂的药代动力学和安全性：一项 2/3 期、开放标签、单臂研究。
Lancet HIV. 2024 May;11(5):e300-e308. doi: 10.1016/S2352-3018(23)00327-2. Epub 2024 Apr 12.
5
Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase 3 randomized, double-blind, multicenter, active-controlled, non-inferiority study.从多替拉韦/阿巴卡韦/拉米夫定转换为比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺的疗效和安全性：一项3期随机、双盲、多中心、活性对照、非劣效性研究的开放标签扩展结果
Medicine (Baltimore). 2025 Feb 21;104(8):e41482. doi: 10.1097/MD.0000000000041482.
6
Impact of switching to bictegravir- or dolutegravir-based antiretroviral therapy on weight in people living with HIV during the COVID-19 pandemic.在新冠疫情期间，转换为基于比克替拉韦或多替拉韦的抗逆转录病毒疗法对HIV感染者体重的影响。
Curr Med Res Opin. 2025 May;41(5):779-787. doi: 10.1080/03007995.2025.2514761. Epub 2025 Jun 5.
7
Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.司他夫定、拉米夫定与奈韦拉平联合疗法治疗成人HIV感染和艾滋病
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD004535. doi: 10.1002/14651858.CD004535.pub2.
8
Treatment persistence among treatment-experienced people with HIV switching to integrase strand transfer inhibitor-based antiretroviral regimens.转换为基于整合酶链转移抑制剂的抗逆转录病毒治疗方案的有HIV治疗经验者的治疗依从性。
J Med Econ. 2025 Jul 18:1-14. doi: 10.1080/13696998.2025.2536422.
9
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低母婴传播HIV感染风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2002(1):CD003510. doi: 10.1002/14651858.CD003510.
10
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低母婴传播HIV感染风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2002(2):CD003510. doi: 10.1002/14651858.CD003510.

本文引用的文献

1
Management of enzyme de-induction in a woman with HIV on methadone maintenance switched from nevirapine- to bictegravir-based antiretroviral regimen.一名接受美沙酮维持治疗的感染艾滋病毒女性，其抗逆转录病毒治疗方案从基于奈韦拉平转换为基于比克替拉韦，酶诱导的管理。
Eur J Clin Pharmacol. 2024 Jul;80(7):1105-1106. doi: 10.1007/s00228-024-03681-x. Epub 2024 Mar 25.
2
Characterization of the time course of carbamazepine deinduction by an enzyme turnover model.用酶转化模型对卡马西平诱导缺失的时程特征进行描述。
Clin Pharmacokinet. 2009;48(5):313-20. doi: 10.2165/00003088-200948050-00003.